These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3281027

  • 1. Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation.
    Fu KK, DeGregorio MW, Phillips JW.
    NCI Monogr; 1988; (6):123-7. PubMed ID: 3281027
    [Abstract] [Full Text] [Related]

  • 2. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
    Douple EB, Totten MD, Spencer F.
    NCI Monogr; 1988; (6):129-32. PubMed ID: 3281028
    [Abstract] [Full Text] [Related]

  • 3. The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma.
    Fu KK, Lam KN, Rayner PA.
    Int J Radiat Oncol Biol Phys; 1985 Dec; 11(12):2119-24. PubMed ID: 4066444
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR, Cai GF.
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Apr; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H, Miyawaki Y, Tokiyoshi K, Tsuruzono K, Yamada M, Kanayama T, Hayakawa T.
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [Abstract] [Full Text] [Related]

  • 7. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 8. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C, Krefeld B, Dinnesen AG, Deuster D, Seifert E, Würthwein G, Jaehde U, Pieck AC, Boos J.
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [Abstract] [Full Text] [Related]

  • 9. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
    Nagase M, Nomura T, Nakajima T.
    Cancer Treat Rep; 1987 Sep; 71(9):825-9. PubMed ID: 3621215
    [Abstract] [Full Text] [Related]

  • 10. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
    Agostinucci WA, Gannon RH, Golub GR, Martin RS, Schauer PK, Dinonno EB.
    Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
    [Abstract] [Full Text] [Related]

  • 11. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL.
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
    Verschraagen M, Boven E, Ruijter R, van der Born K, Berkhof J, Hausheer FH, van der Vijgh WJ.
    Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P.
    Cancer; 2001 Jun 15; 91(12):2369-77. PubMed ID: 11413527
    [Abstract] [Full Text] [Related]

  • 14. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL, LeRoy AF, Guarino AM.
    Cancer Treat Rep; 1979 Jun 15; 63(9-10):1485-92. PubMed ID: 498147
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.